Jay Edelberg

Jay Edelberg MD, PHD is a co-founder and Head of Research and Development of Prolaio. He previously was the Chief Medical Officer at Myokardia, developing Camzyos®, and the Head of the Global Cardiovascular Development at Sanofi, developing Praluent ®.

Dr Edelberg is a clinical cardiologist and vascular biologist. He served on the faculty of Weill Medical College of Cornell University. Dr. Edelberg attended Duke University School of Medicine, was an internal medicine resident at Massachusetts General Hospital and cardiology fellow at Beth Israel Deaconess Medical Center.